Prenetics to Participate in the 38th Annual ROTH Conference
Prenetics (NASDAQ: PRE) will attend the 38th Annual ROTH Conference in Laguna Niguel, CA, March 22–24, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Prenetics (NASDAQ: PRE) will attend the 38th Annual ROTH Conference in Laguna Niguel, CA, March 22–24, 2026. Management will hold one-on-one investor meetings and participate in a fireside chat at 8:30 a.m. PT and a Consumer Influencer panel at 12:00 p.m. PT on Monday, March 23, 2026. Both sessions will be available via webcast on the company’s investor relations website. To schedule meetings, investors should contact Investor Relations or their ROTH representative.
Details
News Market Reaction – PRE
On Mar 18, the day this news came out, PRE closed 1.30% below the previous close.
Data tracked by StockTitan Argus for the Mar 18 session.
Key Figures
- Conference edition
- 38th Annual ROTH Conference
- Event participation
- Conference dates
- March 22–24
- ROTH Conference schedule in Laguna Niguel, CA
- Fireside chat time
- 8:30 a.m. PT
- Management fireside chat on Monday, March 23
- Panel time
- 12:00 p.m. PT
- Consumer Influencer panel on Monday, March 23
Historical Context
-
Authorized a $40M share repurchase with strong liquidity and no debt.
-
Executives completed a second round of post-earnings open-market share buys.
-
Launched IM8 Daily Ultimate Essentials PRO with higher potency and new flavors.
-
Completed $70M Insighta sale, boosting total adjusted liquidity to $171.1M.
-
Reported record FY2025 results with ~480% YoY revenue growth and strong IM8 ARR.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the Company will participate in the 38th Annual ROTH Conference being held Sunday, March 22nd to Tuesday, March 24th at the Ritz-Carlton in Laguna Niguel, CA.
Prenetics CEO Danny Yeung and President of Americas David Vanderveen will be available for one-on-one meetings throughout the conference. Management will also participate in a fireside chat at 8:30 a.m. PT and a Consumer Influencer panel discussion at 12:00 p.m. PT on Monday, March 23rd — both available via webcast at the links above and on the Company’s investor relations website.
To schedule a one-on-one meeting with Prenetics’ management, please contact Investor Relations at PRE@mzgroup.us or your ROTH representative.
About Prenetics
Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company’s flagship consumer brand, IM8, co-founded with David Beckham and championed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing
About IM8
IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health. To learn more about IM8, please visit www.IM8health.com.
Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us
Angela Cheung
Investor Relations / Corporate Finance
angela.hm.cheung@prenetics.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.